GPT and acute myeloid leukemia: To assess the effect of downregulating PSMB10 on AML progression in vivo, we employed an AML xenograft model with NOD/ShiLtJGpt-Prkdcem26Cd52Il2rgem26Cd22/Gpt (NCG) mice (Fig. 3A).